申请人:Bayer Aktiengesellschaft
公开号:US04215131A1
公开(公告)日:1980-07-29
Pharmaceutical compositions free from pathogenic microorganisms which could be harmful to warm-blooded animals, are provided containing, as an active ingredient, an antimicrobially effective amount of at least one compound of the formula ##STR1## in which R represents hydrogen, --CO--R.sup.1 or --SO.sub.2 --R.sup.2, wherein R.sup.1 represents optionally substituted alkyl, alkenyl or alkinyl, optionally substituted phenyl, optionally substituted phenoxyalkyl, phenylalkyl, cycloalkyl, alkylamino, dialkylamino or optionally substituted phenylamino, R.sup.2 represents alkyl or optionally substituted phenyl, A represents a keto group or a --CH(OH)-- grouping, X represents hydrogen or an --OR grouping, wherein R is as defined above, X.sup.1 represents alkyl or optionally substituted phenyl, Y represents --CH-- or a nitrogen atom, Z represents halogen, alkyl, halogenoalkyl, cycloalkyl, alkoxy, alkythio, alkoxycarbonyl, optionally substituted phenyl, optionally substituted phenoxy, optionally substituted phenylalkyl, amino, cyano or nitro and n represents 0 or an integer from 1 to 5, or a salt thereof, in admixture with a sterile pharmaceutical carrier, such as a solid or liquefied gaseous diluent, or with a liquid diluent other than a solvent of molecular weight less than 200 (preferably 300) except in the presence of a surface-active agent. The compositions of the invention are useful as antimycotic agents. Also included in the invention is the provision of the compositions of the invention in unit dosage form as well as the provision of methods of treatment wherein the compositions of the invention are administered to warm-blooded animals.
提供不含对温血动物有害的病原微生物的药物组合物,其包含作为活性成分的至少一种化合物,其化学式为##STR1##其中R代表氢,-CO-R.sup.1或-SO.sub.2-R.sup.2,其中R.sup.1代表可选择地取代的烷基,烯基或炔基,可选择地取代的苯基,可选择地取代的苯氧基烷基,苯基烷基,环烷基,烷基氨基,二烷基氨基或可选择地取代的苯胺基,R.sup.2代表烷基或可选择地取代的苯基,A代表酮基或-CH(OH)-基团,X代表氢或-OR基团,其中R如上定义,X.sup.1代表烷基或可选择地取代的苯基,Y代表-CH-或氮原子,Z代表卤素,烷基,卤代烷基,环烷基,烷氧基,硫代烷基,烷氧羰基,可选择地取代的苯基,可选择地取代的苯氧基,可选择地取代的苯基烷基,氨基,氰基或硝基,n代表0或1到5之间的整数,或其盐,与无菌药用载体混合,例如固体或液化气态稀释剂,或与除分子量小于200(优选300)的溶剂之外的液体稀释剂混合,除非存在表面活性剂。本发明的组合物可用作抗真菌剂。本发明还包括以单位剂量形式提供本发明的组合物以及提供治疗方法,其中将本发明的组合物给予温血动物。